Low-code and modular programming environments are transforming PLC programming, with vendors providing pre-packaged libraries and objects that eliminate traditional IEC-61131-3 style coding, allowing ...

CRH plc’s S&P 500 inclusion may not offset flat earnings, high debt, and lofty valuations. Click here to read an analysis of ...

FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...

Evercore 8th Annual Healthcare Conference December 3, 2025 3:50 PM ESTCompany ParticipantsTerrance Coyne - Executive VP ...

Good afternoon and happy Wednesday readers! On the third day of permitting, Congress gave to me – one leading House Democrat ...

"Whenever he goes to start his career, he will have no issue being hired by a company- they’ll be fortunate to have him." ...

Learn about the documented issues in DHS watchdog corruption that reveal a concerning lack of action on whistleblower disclosures.

Earnings call Chemring reported FY25 revenue of £498M (+2% YoY) and operating profit up 6%, with margins expanding to 14.8%. Record order intake of £781M (+20%) drove a £1.3B backlog (+32%). FY26 ...

By Greta Hentges Communities across our region are taking bold steps toward a more sustainable and resilient future through ...

Tonya Ward Singer shares the power of co-leadership and job-embedded inquiry to build collective efficacy for every teacher ...

Learn more about whether Immunocore Holdings plc or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

The Wisconsin Department of Justice is about to settle a lawsuit in a PFAS contamination case in northeastern Wisconsin.